Gemphire Therapeutics' Bridge Round

Gemphire Therapeutics raised a round of funding on August 07, 2015. Investors include Grand Angels.

Gemphire Therapeutics is a clinical-stage biotech company. The company offers, Gemcabene, an oral once-daily drug candidate, that is being developed to treat the large unmet medical need of patients w…

Articles about Gemphire Therapeutics' Bridge Round: